SGIOF
Shionogi & Co., Ltd.
Price Chart
Latest Quote
$18.00
Current Price| Previous Close | $18.89 |
| Open | $18.00 |
| Day High | $18.00 |
| Day Low | $18.00 |
| Volume | 50 |
Stock Information
Note: Financial values converted from JPY to USD
| Quarterly Dividend / Yield | $0.44 / 2.42% |
| Shares Outstanding | 850.98M |
| Total Debt | $146.54M |
| Cash Equivalents | $1.39B |
| Revenue | $2.99B |
| Net Income | $1.25B |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $18.32B |
| P/E Ratio | 13.74 |
| EPS (TTM) | $1.31 |
| Exchange | PNK |
📊 Custom Metrics & Score
Score: 30/42| Debt to Equity | 0.02 |
| Debt to Earnings | 0.06 |
| Current Ratio | 6.63 |
| Quick Ratio | 4.98 |
| Avg Revenue Growth | 7.69% |
| Profit Margin | 38.89% |
| Return on Equity | 12.51% |
| Avg FCF Growth | 25.83% |
| FCF Yield | 782.56% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-01-30 | $18.10 | 100 |
| 2026-01-29 | $18.89 | 0 |
| 2026-01-28 | $18.89 | 0 |
| 2026-01-27 | $18.89 | 1,600 |
| 2026-01-26 | $18.00 | 0 |
| 2026-01-23 | $18.00 | 0 |
| 2026-01-22 | $18.00 | 0 |
| 2026-01-21 | $18.00 | 0 |
| 2026-01-20 | $18.00 | 0 |
| 2026-01-16 | $18.00 | 0 |
| 2026-01-15 | $18.00 | 0 |
| 2026-01-14 | $18.00 | 0 |
| 2026-01-13 | $18.00 | 0 |
| 2026-01-12 | $18.00 | 0 |
| 2026-01-09 | $18.00 | 0 |
| 2026-01-08 | $18.00 | 0 |
| 2026-01-07 | $18.00 | 600 |
| 2026-01-06 | $15.21 | 0 |
| 2026-01-05 | $15.21 | 0 |
About Shionogi & Co., Ltd.
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.
📰 Latest News
Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership
Insider Monkey • 2026-01-25T19:38:18Z
Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up
Pharmaceutical Technology • 2026-01-20T17:14:06Z
Shionogi (TSE:4507): Evaluating Valuation After a Strong Year-to-Date Share Price Gain
Simply Wall St. • 2025-12-23T11:06:41Z
Fed Outlook, Catalyst Dearth Cap Asian Stock Markets
MT Newswires • 2025-12-10T10:58:22ZShionogi (TSE:4507): Exploring Valuation After Quiet Share Price Gains
Simply Wall St. • 2025-10-23T13:11:34Z
Can Shionogi’s Rally Continue After Key Drug Approval in 2025?
Simply Wall St. • 2025-09-09T11:40:11Z
ViiV’s HIV shot preferred, as activists spotlight funding crisis at IAS 2025
Clinical Trials Arena • 2025-07-15T14:24:16Z
SGIOY or ZTS: Which Is the Better Value Stock Right Now?
Zacks • 2025-07-07T15:40:03Z
BioVersys and Shionogi agree to develop ansamycin leads
Pharmaceutical Technology • 2025-07-03T14:55:20Z
Income Statement (Annual)
Revenue
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $63,826,000,000 | $57,602,000,000 | $62,246,000,000 | $55,415,000,000 |
| Cost Of Revenue | $63,826,000,000 | $57,602,000,000 | $62,246,000,000 | $55,415,000,000 |
| Total Revenue | $438,268,000,000 | $435,081,000,000 | $426,684,000,000 | $335,138,000,000 |
| Operating Revenue | $438,268,000,000 | $435,081,000,000 | $426,684,000,000 | $335,138,000,000 |
Expenses
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Interest Expense | $9,027,000,000 | $6,701,000,000 | $4,500,000,000 | $841,000,000 |
| Total Expenses | $281,663,000,000 | $281,769,000,000 | $277,679,000,000 | $224,825,000,000 |
| Net Non Operating Interest Income Expense | $44,147,000,000 | $44,973,000,000 | $71,329,000,000 | $15,956,000,000 |
| Interest Expense Non Operating | $9,027,000,000 | $6,701,000,000 | $4,500,000,000 | $841,000,000 |
| Operating Expense | $217,837,000,000 | $224,167,000,000 | $215,433,000,000 | $169,410,000,000 |
| Other Operating Expenses | $3,702,000,000 | $24,342,000,000 | $15,445,000,000 | $4,551,000,000 |
| General And Administrative Expense | $101,873,000,000 | $99,651,000,000 | $97,775,000,000 | $91,771,000,000 |
Income & Earnings
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $170,435,000,000 | $162,030,000,000 | $184,965,000,000 | $114,185,000,000 |
| Net Interest Income | $44,147,000,000 | $44,973,000,000 | $71,329,000,000 | $15,956,000,000 |
| Interest Income | $53,174,000,000 | $51,674,000,000 | $75,829,000,000 | $16,797,000,000 |
| Normalized Income | $170,435,000,000 | $162,030,000,000 | $184,965,000,000 | $114,185,000,000 |
| Net Income From Continuing And Discontinued Operation | $170,435,000,000 | $162,030,000,000 | $184,965,000,000 | $114,185,000,000 |
| Total Operating Income As Reported | $156,603,000,000 | $153,310,000,000 | $149,003,000,000 | $110,312,000,000 |
| Net Income Common Stockholders | $170,435,000,000 | $162,030,000,000 | $184,965,000,000 | $114,185,000,000 |
| Net Income | $170,435,000,000 | $162,030,000,000 | $184,965,000,000 | $114,185,000,000 |
| Net Income Including Noncontrolling Interests | $169,534,000,000 | $160,575,000,000 | $184,496,000,000 | $113,439,000,000 |
| Net Income Continuous Operations | $169,535,000,000 | $160,575,000,000 | $184,496,000,000 | $113,439,000,000 |
| Pretax Income | $200,750,000,000 | $198,283,000,000 | $220,332,000,000 | $126,268,000,000 |
| Interest Income Non Operating | $53,174,000,000 | $51,674,000,000 | $75,829,000,000 | $16,797,000,000 |
| Operating Income | $156,604,000,000 | $153,312,000,000 | $149,004,000,000 | $110,312,000,000 |
| Depreciation And Amortization In Income Statement | $4,178,000,000 | $3,728,000,000 | $3,720,000,000 | $3,476,000,000 |
| Depreciation Income Statement | $0 | $0 | $0 | $0 |
| Gross Profit | $374,441,000,000 | $377,479,000,000 | $364,437,000,000 | $279,722,000,000 |
Per Share Metrics
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Diluted EPS | $200.29 | $186.11 | $207.03 | $126.21 |
| Basic EPS | $200.36 | $186.17 | $207.10 | $126.25 |
Other
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $230,710,000,000 | $223,307,000,000 | $241,997,000,000 | $143,460,000,000 |
| Reconciled Depreciation | $20,933,000,000 | $18,323,000,000 | $17,165,000,000 | $16,351,000,000 |
| EBITDA (Bullshit earnings) | $230,710,000,000 | $223,307,000,000 | $241,997,000,000 | $143,460,000,000 |
| EBIT | $209,777,000,000 | $204,984,000,000 | $224,832,000,000 | $127,109,000,000 |
| Diluted Average Shares | $850,941,135 | $870,635,000 | $893,406,859 | $904,737,000 |
| Basic Average Shares | $850,643,841 | $870,333,384 | $893,104,891 | $904,434,000 |
| Diluted NI Availto Com Stockholders | $170,435,000,000 | $162,030,000,000 | $184,965,000,000 | $114,185,000,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Minority Interests | $900,000,000 | $1,455,000,000 | $469,000,000 | $746,000,000 |
| Tax Provision | $31,215,000,000 | $37,708,000,000 | $35,836,000,000 | $12,829,000,000 |
| Amortization | $4,178,000,000 | $3,728,000,000 | $3,720,000,000 | $3,476,000,000 |
| Research And Development | $108,612,000,000 | $102,640,000,000 | $102,392,000,000 | $72,996,000,000 |
| Selling General And Administration | $101,873,000,000 | $99,651,000,000 | $97,775,000,000 | $91,771,000,000 |
Balance Sheet (Annual)
Assets
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Net Tangible Assets | $1,202,524,000,000 | $1,102,417,000,000 | $993,918,000,000 | $884,800,000,000 |
| Total Assets | $1,535,349,000,000 | $1,416,918,000,000 | $1,311,800,000,000 | $1,150,601,000,000 |
| Total Non Current Assets | $676,844,000,000 | $632,712,000,000 | $527,607,000,000 | $491,396,000,000 |
| Other Non Current Assets | $41,872,000,000 | $42,163,000,000 | $6,719,000,000 | $6,060,000,000 |
| Non Current Deferred Taxes Assets | $13,244,000,000 | $13,526,000,000 | $22,100,000,000 | $12,907,000,000 |
| Investmentin Financial Assets | $299,799,000,000 | $292,321,000,000 | $247,711,000,000 | $242,479,000,000 |
| Goodwill And Other Intangible Assets | $159,400,000,000 | $132,908,000,000 | $106,128,000,000 | $90,861,000,000 |
| Other Intangible Assets | $143,652,000,000 | $117,621,000,000 | $96,309,000,000 | $81,223,000,000 |
| Current Assets | $858,504,000,000 | $784,205,000,000 | $784,192,000,000 | $659,205,000,000 |
| Other Current Assets | $27,655,000,000 | $22,608,000,000 | $53,144,000,000 | $25,120,000,000 |
| Inventory | $65,477,000,000 | $64,916,000,000 | $57,919,000,000 | $45,892,000,000 |
| Accounts Receivable | $120,553,000,000 | $122,830,000,000 | $109,774,000,000 | $122,965,000,000 |
| Cash Cash Equivalents And Short Term Investments | $644,819,000,000 | $573,851,000,000 | $563,355,000,000 | $465,177,000,000 |
| Cash And Cash Equivalents | $374,795,000,000 | $358,090,000,000 | $309,224,000,000 | $254,420,000,000 |
| Taxes Receivable | - | - | $68,000,000 | $51,000,000 |
Debt
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Debt | $21,882,000,000 | $11,620,000,000 | $9,411,000,000 | $6,674,000,000 |
| Long Term Debt And Capital Lease Obligation | $18,418,000,000 | $8,753,000,000 | $6,397,000,000 | $3,729,000,000 |
| Current Debt And Capital Lease Obligation | $3,464,000,000 | $2,867,000,000 | $3,014,000,000 | $2,945,000,000 |
Liabilities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $172,853,000,000 | $164,357,000,000 | $189,922,000,000 | $157,316,000,000 |
| Total Non Current Liabilities Net Minority Interest | $43,461,000,000 | $30,450,000,000 | $31,370,000,000 | $32,920,000,000 |
| Other Non Current Liabilities | $4,366,000,000 | $1,694,000,000 | $1,346,000,000 | $356,000,000 |
| Non Current Deferred Taxes Liabilities | $4,401,000,000 | $4,360,000,000 | $5,916,000,000 | $7,807,000,000 |
| Current Liabilities | $129,392,000,000 | $133,907,000,000 | $158,552,000,000 | $124,396,000,000 |
| Other Current Liabilities | $71,859,000,000 | $64,270,000,000 | $69,596,000,000 | $65,079,000,000 |
| Payables | $35,978,000,000 | $35,652,000,000 | $56,222,000,000 | $34,345,000,000 |
| Total Tax Payable | $22,399,000,000 | $20,844,000,000 | $42,217,000,000 | $17,973,000,000 |
| Accounts Payable | $13,579,000,000 | $14,808,000,000 | $14,005,000,000 | $16,372,000,000 |
Equity
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Common Stock Equity | $1,361,924,000,000 | $1,235,325,000,000 | $1,100,046,000,000 | $975,661,000,000 |
| Total Equity Gross Minority Interest | $1,362,496,000,000 | $1,252,561,000,000 | $1,121,878,000,000 | $993,285,000,000 |
| Stockholders Equity | $1,361,924,000,000 | $1,235,325,000,000 | $1,100,046,000,000 | $975,661,000,000 |
| Other Equity Interest | $272,926,000,000 | $271,780,000,000 | $186,031,000,000 | $164,826,000,000 |
| Retained Earnings | $1,115,729,000,000 | $1,065,913,000,000 | $940,606,000,000 | $832,958,000,000 |
Other
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Treasury Shares Number | $38,944,777 | $71,683,764 | $39,240,837 | $30,310,155 |
| Ordinary Shares Number | $850,687,418 | $850,474,731 | $882,917,658 | $904,448,340 |
| Share Issued | $889,632,195 | $922,158,495 | $922,158,495 | $934,758,495 |
| Tangible Book Value | $1,202,524,000,000 | $1,102,417,000,000 | $993,918,000,000 | $884,800,000,000 |
| Invested Capital | $1,361,924,000,000 | $1,235,325,000,000 | $1,100,046,000,000 | $975,661,000,000 |
| Working Capital | $729,112,000,000 | $650,298,000,000 | $625,640,000,000 | $534,809,000,000 |
| Capital Lease Obligations | $21,882,000,000 | $11,620,000,000 | $9,411,000,000 | $6,674,000,000 |
| Total Capitalization | $1,361,924,000,000 | $1,235,325,000,000 | $1,100,046,000,000 | $975,661,000,000 |
| Minority Interest | $572,000,000 | $17,236,000,000 | $21,832,000,000 | $17,624,000,000 |
| Treasury Stock | $65,855,000,000 | $137,889,000,000 | $63,074,000,000 | $57,857,000,000 |
| Additional Paid In Capital | $17,845,000,000 | $14,242,000,000 | $15,204,000,000 | $14,455,000,000 |
| Capital Stock | $21,279,000,000 | $21,279,000,000 | $21,279,000,000 | $21,279,000,000 |
| Common Stock | $21,279,000,000 | $21,279,000,000 | $21,279,000,000 | $21,279,000,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $8,018,000,000 | $7,994,000,000 | $12,867,000,000 | $15,412,000,000 |
| Long Term Capital Lease Obligation | $18,418,000,000 | $8,753,000,000 | $6,397,000,000 | $3,729,000,000 |
| Current Capital Lease Obligation | $3,464,000,000 | $2,867,000,000 | $3,014,000,000 | $2,945,000,000 |
| Available For Sale Securities | $299,799,000,000 | $292,321,000,000 | $247,711,000,000 | $242,479,000,000 |
| Investment Properties | $27,722,000,000 | $27,768,000,000 | $26,382,000,000 | $26,672,000,000 |
| Goodwill | $15,748,000,000 | $15,287,000,000 | $9,819,000,000 | $9,638,000,000 |
| Net PPE | $134,807,000,000 | $124,026,000,000 | $118,567,000,000 | $112,417,000,000 |
| Gross PPE | $134,807,000,000 | $124,026,000,000 | $118,567,000,000 | $112,417,000,000 |
| Other Properties | $134,807,000,000 | $124,026,000,000 | $118,567,000,000 | $112,417,000,000 |
| Other Short Term Investments | $270,024,000,000 | $215,761,000,000 | $254,131,000,000 | $210,757,000,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Free Cash Flow | $143,357,000,000 | $126,017,000,000 | $140,680,000,000 | $70,504,000,000 |
Operating Activities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Operating Cash Flow | $195,460,000,000 | $154,284,000,000 | $177,867,000,000 | $102,068,000,000 |
Investing Activities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Capital Expenditure | $-52,103,000,000 | $-28,267,000,000 | $-37,187,000,000 | $-31,564,000,000 |
| Investing Cash Flow | $-116,080,000,000 | $5,922,000,000 | $-48,292,000,000 | $-96,204,000,000 |
| Net Other Investing Changes | $-1,853,000,000 | $-2,862,000,000 | $3,306,000,000 | $940,000,000 |
Financing Activities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Repurchase Of Capital Stock | $-10,000,000 | $-75,182,000,000 | $-49,539,000,000 | $-14,000,000 |
| Financing Cash Flow | $-64,908,000,000 | $-126,853,000,000 | $-84,123,000,000 | $-36,615,000,000 |
| Net Other Financing Charges | $-12,990,000,000 | $-4,715,000,000 | $4,716,000,000 | $-2,000,000 |
| Cash Dividends Paid | $-48,698,000,000 | $-43,876,000,000 | $-36,142,000,000 | $-33,146,000,000 |
| Common Stock Dividend Paid | $-48,698,000,000 | $-43,876,000,000 | $-36,142,000,000 | $-33,146,000,000 |
| Net Common Stock Issuance | $-10,000,000 | $-75,182,000,000 | $-49,539,000,000 | $-14,000,000 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
Other
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| End Cash Position | $374,795,000,000 | $358,090,000,000 | $309,224,000,000 | $254,420,000,000 |
| Beginning Cash Position | $358,090,000,000 | $309,224,000,000 | $254,420,000,000 | $276,173,000,000 |
| Effect Of Exchange Rate Changes | $2,233,000,000 | $15,512,000,000 | $9,352,000,000 | $8,998,000,000 |
| Changes In Cash | $14,472,000,000 | $33,353,000,000 | $45,452,000,000 | $-30,751,000,000 |
| Common Stock Payments | $-10,000,000 | $-75,182,000,000 | $-49,539,000,000 | $-14,000,000 |
| Net Investment Purchase And Sale | $-60,799,000,000 | $64,547,000,000 | $-14,411,000,000 | $-65,580,000,000 |
| Sale Of Investment | $377,701,000,000 | $349,391,000,000 | $467,857,000,000 | $334,196,000,000 |
| Purchase Of Investment | $-438,500,000,000 | $-284,844,000,000 | $-482,268,000,000 | $-399,776,000,000 |
| Net Business Purchase And Sale | $-1,325,000,000 | $-27,496,000,000 | $0 | $0 |
| Purchase Of Business | $-1,325,000,000 | $-27,496,000,000 | $0 | $0 |
| Net Intangibles Purchase And Sale | $-34,977,000,000 | $-15,574,000,000 | $-25,329,000,000 | $-5,379,000,000 |
| Purchase Of Intangibles | $-34,977,000,000 | $-15,574,000,000 | $-25,329,000,000 | $-5,379,000,000 |
| Net PPE Purchase And Sale | $-17,126,000,000 | $-12,693,000,000 | $-11,858,000,000 | $-26,185,000,000 |
| Purchase Of PPE | $-17,126,000,000 | $-12,693,000,000 | $-11,858,000,000 | $-26,185,000,000 |
| Taxes Refund Paid | $-31,817,000,000 | $-63,637,000,000 | $-27,284,000,000 | $-26,038,000,000 |
| Interest Received Cfo | $52,190,000,000 | $49,324,000,000 | $49,716,000,000 | $24,807,000,000 |
| Interest Paid Cfo | $-305,000,000 | $-164,000,000 | $-94,000,000 | $-87,000,000 |
| Change In Working Capital | $-181,000,000 | $-24,526,000,000 | $9,980,000,000 | $-38,864,000,000 |
| Change In Payable | $-1,703,000,000 | $-5,817,000,000 | $7,738,000,000 | $11,686,000,000 |
| Change In Inventory | $-388,000,000 | $-6,337,000,000 | $-11,699,000,000 | $-7,133,000,000 |
| Change In Receivables | $1,910,000,000 | $-12,372,000,000 | $13,941,000,000 | $-43,417,000,000 |
| Other Non Cash Items | $-46,363,000,000 | $-31,580,000,000 | $-103,706,000,000 | $-510,000,000 |
| Depreciation And Amortization | $20,933,000,000 | $18,323,000,000 | $17,165,000,000 | $16,351,000,000 |
| Depreciation | $20,933,000,000 | $18,323,000,000 | $17,165,000,000 | $16,351,000,000 |
| Net Income From Continuing Operations | $200,750,000,000 | $198,283,000,000 | $220,332,000,000 | $126,268,000,000 |
| Other Cash Adjustment Outside Changein Cash | - | $1,000,000 | - | - |
| Sale Of PPE | - | - | - | - |